Secretory leukocyte protease inhibitor and lung inflammation in developing bronchopulmonary dysplasia

This publication has 19 references indexed in Scilit:

• Protease inhibitors in bronchoalveolar lavage fluid from neonates with special reference to secretory leukocyte protease inhibitor
  Acta Paediatrica, 1992
• Elastase activity and surfactant protein concentration in tracheal aspirates from neonates receiving synthetic surfactant
  The Journal of Pediatrics, 1992
• Multivariate assessment of traditional risk factors for chronic lung disease in very low birth weight neonates
  The Journal of Pediatrics, 1991
• Role of Antileukoprotease in the Human Lung
  Annals of the New York Academy of Sciences, 1991
• Antileukoprotease-containing Bronchiolar Cells: Relationship with Morphologic Disease of Small Airways and Parenchyma
  American Review of Respiratory Disease, 1989
• Tissue distribution of antileukoprotease and lysozyme in humans.
  Journal of Histochemistry & Cytochemistry, 1989
• Effects of dexamethasone and indomethacin on elastase, α1-proteinase inhibitor, and fibronectin in bronchoalveolar lavage fluid from neonates
  The Journal of Pediatrics, 1988
• Human surfactant treatment of severe respiratory distress syndrome: Pulmonary effluent indicators of lung inflammation
  The Journal of Pediatrics, 1986
• Elastase and alpha 1-proteinase inhibitor activity in tracheal aspirates during respiratory distress syndrome. Role of inflammation in the pathogenesis of bronchopulmonary dysplasia.
  Journal of Clinical Investigation, 1983
• Antielastases of the human alveolar structures. Implications for the protease-antiprotease theory of emphysema.
  Journal of Clinical Investigation, 1981